{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:40:45Z","timestamp":1787168445414,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Taipei City Hospital","award":["10301-62-029"],"award-info":[{"award-number":["10301-62-029"]}]},{"name":"Ministry of Science & Technology, Executive Yuan","award":["107-2314-B-075-051-MY3"],"award-info":[{"award-number":["107-2314-B-075-051-MY3"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.npep.2020.102100","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T03:04:54Z","timestamp":1603681494000},"page":"102100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Increased monocyte chemoattractant protein-1 and nitrotyrosine are associated with increased body weight in patients with rheumatoid arthritis after etanercept therapy"],"prefix":"10.1016","volume":"84","author":[{"given":"Hsien-Hao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Youh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.npep.2020.102100_bb0005","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an american college of rheumatology\/european league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.npep.2020.102100_bb0010","first-page":"3338","article-title":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss","volume":"85","author":"Bastard","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.npep.2020.102100_bb0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"2","key":"10.1016\/j.npep.2020.102100_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/rheumatology\/ket255","article-title":"From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis?","volume":"53","author":"Chen","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.npep.2020.102100_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1726-4901(10)70048-4","article-title":"Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans","volume":"73","author":"Chen","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"issue":"10","key":"10.1016\/j.npep.2020.102100_bb0030","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/1381612811319100014","article-title":"Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin","volume":"19","author":"Chen","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.npep.2020.102100_bb0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.ijo.0802839","article-title":"Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects","volume":"29","author":"Christiansen","year":"2005","journal-title":"Int. J. Obes. (Lond)"},{"issue":"2","key":"10.1016\/j.npep.2020.102100_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2010.12.035","article-title":"Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation","volume":"215","author":"Codo\u00f1er-Franch","year":"2011","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.npep.2020.102100_bb0045","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1136\/annrheumdis-2014-206254","article-title":"Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis","volume":"73","author":"Ellerby","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"14","key":"10.1016\/j.npep.2020.102100_bb0050","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","article-title":"Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation","volume":"165","author":"Escalante","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.npep.2020.102100_bb0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2249.2008.03691.x","article-title":"Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis","volume":"153","author":"Fabre","year":"2008","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.npep.2020.102100_bb0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","article-title":"Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases","volume":"51","author":"Farrell","year":"1992","journal-title":"Ann. Rheum. Dis."},{"issue":"1\u20132","key":"10.1016\/j.npep.2020.102100_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0303-7207(01)00394-X","article-title":"Chemokines control fat accumulation and leptin secretion by cultured human adipocytes","volume":"175","author":"Gerhardt","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.npep.2020.102100_bb0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/oby.2008.542","article-title":"Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery","volume":"17","author":"Gletsu-Miller","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.npep.2020.102100_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/acr.21768","article-title":"Obesity and reduction of the response rate to anti-tumor necrosis factor \u03b1 in rheumatoid arthritis: an approach to a personalized medicine","volume":"65","author":"Gremese","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"3","key":"10.1016\/j.npep.2020.102100_bb0080","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/ard.2005.037176","article-title":"Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis","volume":"65","author":"Haringman","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.npep.2020.102100_bb0085","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar2706","article-title":"Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis","volume":"11","author":"Hueber","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.npep.2020.102100_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jbspin.2014.12.006","article-title":"Obesity reduces the drug survival of second line biological drugs following a first TNF-\u03b1 inhibitor in rheumatoid arthritis patients","volume":"82","author":"Iannone","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"21","key":"10.1016\/j.npep.2020.102100_bb0095","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.0000038140.80105.AD","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice","volume":"106","author":"Inoue","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.npep.2020.102100_bb0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/s10165-009-0175-z","article-title":"Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis","volume":"19","author":"Kageyama","year":"2009","journal-title":"Mod. Rheumatol."},{"issue":"9","key":"10.1016\/j.npep.2020.102100_bb0105","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/rheumatology\/40.9.988","article-title":"Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis","volume":"40","author":"Katrib","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 6","key":"10.1016\/j.npep.2020.102100_bb0110","first-page":"vi5","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.npep.2020.102100_bb0115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/03009742.2012.698300","article-title":"Role of peroxynitrite-modified H2A histone in the induction and progression of rheumatoid arthritis","volume":"41","author":"Khan","year":"2012","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.npep.2020.102100_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.06.006","article-title":"Peroxynitrite-modified histone as a pathophysiological biomarker in autoimmune diseases","volume":"140","author":"Khan","year":"2017","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.npep.2020.102100_bb0125","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.ijo.0803259","article-title":"Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters","volume":"30","author":"Kim","year":"2006","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.npep.2020.102100_bb0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.30136","article-title":"Body mass index and clinical response to infliximab in rheumatoid arthritis","volume":"63","author":"Klaasen","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.npep.2020.102100_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00296-009-1299-3","article-title":"Serum chemokines in patients with rheumatoid arthritis treated with etanercept","volume":"31","author":"Klimiuk","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.npep.2020.102100_bb0140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2017.02.003","article-title":"Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-\u03b1 agents in rheumatic diseases; a systematic review and meta-analysis","volume":"79","author":"Komaki","year":"2017","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.npep.2020.102100_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-016-3490-8","article-title":"Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice","volume":"36","author":"Lenert","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.npep.2020.102100_bb0150","article-title":"Etanercept for the treatment of rheumatoid arthritis","volume":"5","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.npep.2020.102100_bb0155","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1152\/ajpendo.00094.2017","article-title":"Effects and mechanisms of caffeine to improve immunological and metabolic abnormalities in diet-induced obese rats","volume":"314","author":"Liu","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"supp. 1","key":"10.1016\/j.npep.2020.102100_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.npep.2020.102100_bb0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.joca.2012.09.005","article-title":"Characterization of nitrotyrosine as a biomarker for arthritis and joint injury","volume":"21","author":"Misko","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"10.1016\/j.npep.2020.102100_bb0170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/annrheumdis-2016-210713","article-title":"Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"76","author":"Nam","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.npep.2020.102100_bb0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s002960100105","article-title":"Elevated levels of nitrate in rheumatoid arthritis","volume":"20","author":"Onur","year":"2001","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.npep.2020.102100_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"issue":"3\u20134","key":"10.1016\/j.npep.2020.102100_bb0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molimm.2012.06.006","article-title":"RANTES, MCP-1 chemokines and factors describing rheumatoid arthritis","volume":"52","author":"Pavkova Goldbergova","year":"2012","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.npep.2020.102100_bb0190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3899\/jrheum.140673","article-title":"Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient","volume":"42","author":"Pers","year":"2015","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.npep.2020.102100_bb0195","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein 1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.npep.2020.102100_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1381\/096089206777346763","article-title":"Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity","volume":"16","author":"Schernthaner","year":"2006","journal-title":"Obes. Surg."},{"issue":"1","key":"10.1016\/j.npep.2020.102100_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.npep.2020.102100_bb0210","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.npep.2020.102100_bb0215","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0006-291X(03)00771-X","article-title":"Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells","volume":"305","author":"Tabata","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"47","key":"10.1016\/j.npep.2020.102100_bb0220","doi-asserted-by":"crossref","first-page":"46654","DOI":"10.1074\/jbc.M309895200","article-title":"Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice","volume":"278","author":"Takahashi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 2","key":"10.1016\/j.npep.2020.102100_bb0225","doi-asserted-by":"crossref","first-page":"ii15","DOI":"10.1093\/rheumatology\/kew352","article-title":"Stopping tumour necrosis factor-targeted biological DMARDs in rheumatoid arthritis","volume":"55","author":"Tanaka","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.npep.2020.102100_bb0230","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/hc0502.103331","article-title":"Weight loss reduces C-reactive protein levels in obese postmenopausal women","volume":"105","author":"Tchernof","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.npep.2020.102100_bb0235","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.amjcard.2011.10.008","article-title":"High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women","volume":"109","author":"Vazquez","year":"2012","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.npep.2020.102100_bb0240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.npep.2020.102100_bb0245","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3349\/ymj.2015.56.4.1134","article-title":"Chemokine signaling pathway involved in CCL2 expression in patients with rheumatoid arthritis","volume":"56","author":"Zhang","year":"2015","journal-title":"Yonsei Med. J."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417920301189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417920301189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:35:59Z","timestamp":1758918959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417920301189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":49,"alternative-id":["S0143417920301189"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2020.102100","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased monocyte chemoattractant protein-1 and nitrotyrosine are associated with increased body weight in patients with rheumatoid arthritis after etanercept therapy","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2020.102100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102100"}}